​2019 Participants

---

Carl Alden, D.V.M., DACVP
Mayflower Pharma

Jim Allison, Ph.D.
The University of Texas MD Anderson Cancer Center

Andy Beck, M.D., Ph.D.
PathAI

Shelley Berger, Ph.D.
University of Pennsylvania

Bradley Bernstein, M.D., Ph.D.
Massachusetts General Hospital

Mike Bishop, M.D.
University of California, San Francisco

Elizabeth Blackburn, Ph.D.
University of California, San Francisco

Joan Brugge, Ph.D.
Havard Medical School

Webster K. Cavenee, Ph.D.
University of California, San Diego

Michael Cima, Ph.D.
Massachusetts Institute of Technology

Lewis Chodosh, M.D., Ph.D.
University of Pennsylvania

Heather Christofk, Ph.D.
University of California, Los Angeles

Carlo Croce, M.D.
The Ohio State University Comprehensive Cancer Center

Alan D’Andrea, M.D.
Dana-Farber Cancer Institute

Cathryn Dhanatya, Ph.D.
Stand Up To Cancer

Luis Diaz, M.D.
Memorial Sloan Kettering Cancer Center

Brian Druker, M.D.
Oregon Health & Science University Knight Cancer Center

Raymond N. DuBois, M.D., Ph.D.
The Medical University of South Carolina

John Evanoff, M.S., Ph.D.
University of Texas Medical Branch, Retired

Stephen Fesik, Ph.D.
Vanderbilt University School of Medicine

Jessica Fortin, D.V.M., Ph.D.
Michigan State University

Tona Gilmer, Ph.D.
XRad Therapeutics

Curtis C. Harris, M.D.
Georgetown School of Medicine

Lee Helman, M.D.
Children’s Hospital, Los Angeles

Catherine L. Higgins, Ph.D.
Stand Up To Cancer

​Perwez Hussain, Ph.D.
Brinklow, MD

Elizabeth Jaffee, M.D.
Johns Hopkins University

Roy Jensen, M.D.
University of Kansas Medical Center

Peter Jones, Ph.D., DSc (hon)
Van Andel Institute

Carl June, M.D.
University of Pennsylvania

Willliam G. Kaelin, Jr., M.D.
Dana-Farber Cancer Institute

Michael Kastan, M.D., Ph.D.
Duke Cancer Institute

Scott Lowe, Ph.D.
Memorial Sloan Kettering Cancer Center

Kevin Marks, Ph.D.
Agios Pharmaceuticals, Inc.

Michael Melner, Ph.D.
American Cancer Society

William Nelson, M.D., Ph.D.
Johns Hopkins University School of Medicine

Funmi Olopade, M.B.B.S.
University of Chicago

Drew Pardoll, M.D., Ph.D.
Johns Hopkins University School of Medicine

Elizabeth Plimack, M.D., M.S.
Fox Chase Cancer Center

Sung Poblete, RN, Ph.D.
Stand Up To Cancer

Robert Radinsky, Ph.D.
Janssen Research & Development

Aviv Regev, Ph.D.
Broad Institute of Massachusetts and Harvard

Mark Rolfe, Ph.D.
Celgene

Brid Ryan, Ph.D., M.P.H.
Bethesda, MD

Subrata Sen, Ph.D.
The University of Texas MD Anderson Cancer Center

Peter Shields, M.D.
The Ohio State University Comprehensive Cancer Center

Kevan Shokat, Ph.D.
University of California, San Francisco

Frank Slack, Ph.D.
Harvard Medical School

Kimberly Stegmaier, M.D.
Dana-Farber Cancer Institute

Martin Stumpe, Ph.D.
Google Health AI

Steven Tannenbaum, Ph.D.
Massachusetts Institute of Technology

Thea Tlsty, Ph.D.
University of California, San Francisco

Suzanne Topalian, M.D.
Johns Hopkins University School of Medicine

David Tuveson, M.D., Ph.D.
Cold Spring Harbor Laboratory

Andrea Ventura, Ph.D.
Memorial Sloan Kettering Cancer Center

Cheryl L. Walker, Ph.D.
Baylor College of Medicine

Stuart Yuspa, M.D.
National Cancer Institute